We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Global Anesthesia and Respiratory Devices Market to Reach USD 38 Billion by 2023

By HospiMedica International staff writers
Posted on 01 Mar 2019
The global anesthesia and respiratory devices market is expected to grow at a CAGR of 7.2% from USD 25.21 billion in 2017 to USD 38.29 billion by 2023, driven by the rising prevalence of respiratory diseases, increase in the number of surgical procedures, surge in pollution levels, higher tobacco consumption, rapid urbanization and supportive government policies. More...
However, risks related to therapeutic and diagnostic devices for neonates and the low adoption rate of new technologies will restrain the market growth. Nevertheless, an increase in the demand for therapeutic devices for homecare settings and a surge in healthcare expenditures will create new opportunities in the global anesthesia and respiratory devices market.

These are the latest findings of Allied Market Research (Portland, OR, USA), a full-service market research and business consulting firm.

Based on product type, the respiratory devices segment is the most lucrative and held nearly three-fifths of the total market share in 2017, owing to the high prevalence of respiratory diseases and availability of advanced respiratory devices. The segment is expected to maintain its dominance and grow at the fastest CAGR of 7.3% during the forecast period, driven by a significant rise in pollution across the world, lack of awareness about the utilization of masks for protection against aerosols and other particulate matter, and rising prevalence of respiratory diseases such as asthma, respiratory infections, and tuberculosis. Based on end user, the hospitals segment dominates the anesthesia and respiratory devices market, although the clinics segment is expected to grow at the highest CAGR during the forecast period.

Geographically, North America held two-fifths of the share in the global anesthesia and respiratory devices market in 2017. The North American market is expected to maintain its dominant share throughout the forecast period due to technological advancements in medications & surgical equipment and the rising adoption of modern anesthetics in the region. However, the market in Asia-Pacific is projected to register the highest CAGR of 8.1% during the forecast period, driven by a surge in respiratory disorders such as COPD, asthma, and lung cancer, increase in the geriatric population and growing inclination toward homecare monitoring in the region.

Related Links:
Allied Market Research


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.